CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 99 filers reported holding CALITHERA BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $374,000 | +544.8% | 154,533 | +1207.1% | 0.00% | – |
| Q4 2020 | $58,000 | -45.3% | 11,823 | -61.5% | 0.00% | -100.0% |
| Q3 2020 | $106,000 | -38.4% | 30,690 | -20.9% | 0.00% | -75.0% |
| Q1 2020 | $172,000 | -70.5% | 38,790 | -62.0% | 0.00% | +33.3% |
| Q4 2019 | $583,000 | +322.5% | 102,094 | +189.2% | 0.00% | +200.0% |
| Q2 2019 | $138,000 | -50.5% | 35,306 | -33.7% | 0.00% | -66.7% |
| Q3 2018 | $279,000 | -4.8% | 53,236 | -9.2% | 0.00% | -25.0% |
| Q2 2018 | $293,000 | -31.7% | 58,631 | -14.0% | 0.00% | -42.9% |
| Q1 2018 | $429,000 | -29.4% | 68,160 | -6.3% | 0.01% | -36.4% |
| Q4 2017 | $608,000 | +34.8% | 72,756 | +139.3% | 0.01% | +22.2% |
| Q2 2017 | $451,000 | +229.2% | 30,400 | +155.5% | 0.01% | +125.0% |
| Q1 2017 | $137,000 | +80.3% | 11,900 | -49.1% | 0.00% | +33.3% |
| Q4 2016 | $76,000 | -15.6% | 23,400 | +100.0% | 0.00% | -70.0% |
| Q4 2015 | $90,000 | – | 11,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,290,000 | 3.82% |
| BVF INC/IL | 7,452,331 | $16,246,000 | 0.63% |
| TSP Capital Management Group, LLC | 661,600 | $1,442,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,245 | $406,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 525,667 | $1,146,000 | 0.12% |
| Parkman Healthcare Partners LLC | 100,628 | $219,000 | 0.06% |
| FEDERATED HERMES, INC. | 6,668,978 | $14,539,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 133,700 | $291,000 | 0.02% |
| Ergoteles LLC | 274,805 | $599,000 | 0.02% |
| Seelaus Asset Management LLC | 16,150 | $35,000 | 0.02% |